MAINTAIN - MAintain Functions and INTrinsec capacities with Aging :
Preventive and personalized INterventional Research

Equipe constitutive du CERPOP, UMR 1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Bruno VELLAS •  chercheur

  1. Belleville S, Cloutier S, Mellah S, Willis S, Vellas B, Andrieu S, Coley N, Ngandu T; MAPT/DSA group. Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia. Alzheimers Dement. 2022 Jan 20. doi: 10.1002/alz.12544. Epub ahead of print.
  2. Bischoff-Ferrari HA, Freystätter G, Vellas B, Dawson-Hughes B, Kressig RW, Kanis JA, Willett WC, Manson JE, Rizzoli R, Theiler R, Hofbauer LC, Armbrecht G, da Silva JAP, Blauth M, de Godoi Rezende Costa Molino C, Lang W, Siebert U, Egli A, Orav EJ, Wieczorek M; DO-HEALTH Research Group. Effects of vitamin D, omega-3 fatty acids and a simple home strength exercise program on fall prevention: the DO-HEALTH randomized clinical trial. Am J Clin Nutr. 2022 Feb 7:nqac022. doi: 10.1093/ajcn/nqac022. Epub ahead of print.
  3. Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B. Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease. Alzheimers Dement. 2022 Mar 31. doi: 10.1002/alz.12651. Epub ahead of print.
  4. Calcaterra L, Proietti M, Saporiti E, Nunziata V, Rolland Y, Vellas B, Cesari M. Predictors of drug prescription in nursing home residents: results from the INCUR study. Intern Emerg Med. 2022 Jan;17(1):165-171. doi: 10.1007/s11739-021-02841-6.
  5. Cesari M, Bernabei R, Vellas B, Fielding RA, Rooks D, Azzolino D, Mariani J, Oliva AA, Bhasin S, Rolland Y. Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force. J Frailty Aging. 2022;11(2):135-142. doi: 10.14283/jfa.2022.30.
  6. de Souto Barreto P, Fabre D, Vellas B, Blain H, Molinier L, Rolland Y. Reduction prevalence of fragility fracture hospitalisation during the COVID-19 lockdown. Arch Osteoporos. 2022 Apr 18;17(1):68. doi: 10.1007/s11657-022-01099-5.
  7. de Souto Barreto P, Cesari M, Morley JE, Roberts S, Landi F, Cederholm T, Rolland Y, Vellas B, Fielding R. Appetite Loss and Anorexia of Aging in Clinical Care: An ICFSR Task Force Report. J Frailty Aging. 2022;11(2):129-134. doi: 10.14283/jfa.2022.14.
  8. Fougère B, Goisser S, Cantet C, Soriano G, Guyonnet S, De Souto Barreto P, Cesari M, Andrieu S, Vellas B; MAPT Study Group. Retraction Note to: Omega-3 fatty acid levels in red blood cell membranes and physical decline over 3 years: longitudinal data from the MAPT study. Geroscience. 2022 Jan 5. doi: 10.1007/s11357-021-00505-z. Epub ahead of print.
  9. Gonthier R, Adolphe M, Michel JP, Bringer J, Dubois B, Lecomte D, Milliez J, Vellas B; commission XIII (autonomie-dépendance-vieillissement) de l’Académie nationale de médecine. Rapport 22-02. Après la crise COVID, quelles solutions pour l’EHPAD de demain ? [After the COVID crisis, what solutions for the future nursing home?]. Bull Acad Natl Med. 2022 Feb 19. French. doi: 10.1016/j.banm.2022.02.010. Epub ahead of print.
  10. Gonzalez-Bautista E, Barreto PS, Salinas-Rodriguez A, Manrique Espinoza B, Sourdet S, Rolland Y, Rodriguez-Mañas L, Andrieu S, Vellas B; MAPT/DSA group. Development and validation of a cut-off for the chair stand test as a screening for mobility impairment in the context of the integrated care for older people (ICOPE) program. J Gerontol A Biol Sci Med Sci. 2022 Feb 28:glac055. doi: 10.1093/gerona/glac055. Epub ahead of print.
  11. Giudici KV, Guyonnet S, Morley JE, Nguyen AD, Aggarwal G, Parini A, Li Y, Bateman RJ, Vellas B, Barreto PS; MAPT/DSA group. Interactions between weight loss and plasma neurodegenerative markers for determining cognitive decline among community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2022 Jan 16:glac015. doi: 10.1093/gerona/glac015. Epub ahead of print.
  12. He L, Barreto PS, Sánchez Sánchez JL, Rolland Y, Guyonnet S, Parini A, Lucas A, Vellas B; MAPT/DSA Group. Prospective associations of plasma growth differentiation factor 15 with physical performance and cognitive functions in older adults. J Gerontol A Biol Sci Med Sci. 2022 Jan 17:glac020. doi: 10.1093/gerona/glac020. Epub ahead of print.
  13. Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Baret-Rose C, Tréluyer JM, Abdoul H, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P, Godefroy O, Camus V, Belmin J, Vandel P, Novella JL, Duron E, Rigaud AS, Schraen-Maschke S, Gabelle A; BALTAZAR study group. Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study. Alzheimers Dement. 2022 Feb 20. doi: 10.1002/alz.12613. Epub ahead of print.
  14. Kemoun P, Ader I, Planat-Benard V, Dray C, Fazilleau N, Monsarrat P, Cousin B, Paupert J, Ousset M, Lorsignol A, Raymond-Letron I, Vellas B, Valet P, Kirkwood T, Beard J, Pénicaud L, Casteilla L. A gerophysiology perspective on healthy ageing. Ageing Res Rev. 2022 Jan;73:101537. doi: 10.1016/j.arr.2021.101537.
  15. Lu WH, Giudici KV, Morley JE, Guyonnet S, Parini A, Aggarwal G, Nguyen AD, Li Y, Bateman RJ, Vellas B, de Souto Barreto P; MAPT/DSA Group. Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults. Geroscience. 2022 Apr 20. doi: 10.1007/s11357-022-00554-y. Epub ahead of print.
  16. Lu WH, Vellas B, de Souto Barreto P. Reply to: Comment on: The associations of plasma neurofilament light chain and progranulin with frailty in older adults. J Am Geriatr Soc. 2022 Apr 13. doi: 10.1111/jgs.17782. Epub ahead of print.
  17. Mortamais M, Gutierrez LA, Balem M, Bars EL, de Champfleur NM, Bouyahia A, Chupin M, Perus L, Fisher C, Vellas B, Andrieu S, Mangin JF, Berr C, Gabelle A; MAPT/DSA study group. Sulcal morphology as cognitive decline predictor in older adults with memory complaints. Neurobiol Aging. 2022 May;113:84-94. doi: 10.1016/j.neurobiolaging.2022.02.003.
  18. Mura T, Coley N, Amieva H, Berr C, Gabelle A, Ousset PJ, Vellas B, Andrieu S; GuidAge/DSA study group*. Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials. Alzheimers Dement. 2022 Apr;18(4):676-687. doi: 10.1002/alz.12431.
  19. Oviedo-Briones M, Rodríguez-Laso Á, Carnicero JA, Gryglewska B, Sinclair AJ, Landi F, Vellas B, Rodríguez Artalejo F, Checa-López M, Rodriguez-Mañas L. The ability of eight frailty instruments to identify adverse outcomes across different settings: the FRAILTOOLS project. J Cachexia Sarcopenia Muscle. 2022 Apr 15. doi: 10.1002/jcsm.12990. Epub ahead of print.
  20. Pagès A, Costa N, González-Bautista E, Mounié M, Juillard-Condat B, Molinier L, Cestac P, Rolland Y, Vellas B, De Souto Barreto P; MAPT/DSA Group. Screening for deficits on intrinsic capacity domains and associated healthcare costs. Arch Gerontol Geriatr. 2022 May-Jun;100:104654. doi: 10.1016/j.archger.2022.104654.
  21. Raffin J, Angioni D, Giudici KV, Valet P, Aggarwal G, Nguyen AD, Morley JE, Guyonnet S, Rolland Y, Vellas B, Barreto PS; MAPT/DSA Group. Physical activity, body mass index, and blood progranulin in older adults: cross-sectional associations in the MAPT study. J Gerontol A Biol Sci Med Sci. 2022 Jan 17:glac018. doi: 10.1093/gerona/glac018. Epub ahead of print.
  22. Sanchez-Sanchez JL, Giudici KV, Guyonnet S, Delrieu J, Li Y, Bateman RJ, Parini A, Vellas B, de Souto Barreto P; MAPT/DSA Group. Plasma MCP-1 and changes on cognitive function in community-dwelling older adults. Alzheimers Res Ther. 2022 Jan 7;14(1):5. doi: 10.1186/s13195-021-00940-2.
  23. Schietzel S, Chocano-Bedoya PO, Sadlon A, Gagesch M, Willett WC, Orav EJ, Kressig RW, Vellas B, Rizzoli R, da Silva JAP, Blauth M, Kanis JA, Egli A, Bischoff-Ferrari HA. Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries. BMC Geriatr. 2022 Mar 2;22(1):174. doi: 10.1186/s12877-022-02755-8.
  24. Stahl-Gugger A, de Godoi Rezende Costa Molino C, Wieczorek M, Chocano-Bedoya PO, Abderhalden LA, Schaer DJ, Spahn DR, Orav EJ, Vellas B, da Silva JAP, Kressig RW, Egli A, Bischoff-Ferrari HA; DO-HEALTH Research Group. Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial. Aging Clin Exp Res. 2022 Mar 18. doi: 10.1007/s40520-022-02093-0. Epub ahead of print.
Bruno VELLAS Publications 2021 I Publications 2020 I Publications 2019